Janne Larsson, an investigator and reporter in Sweden, has obtained information about adverse event reports on Eli Lilly's ADHD drug Strattera, using the Swedish freedom of information laws. The data, coming from both the FDA's adverse reaction database and from reports to the UK's Medicines agency, shows numerous adverse effects and scores of deaths by suicide. Yet the agency, even after repeated prodding by Larsson to initiate action, has refused to budge or even acknowledge that there is a problem. MHRA apparently accepts the drug's producer Eli Lilly's data rather than its own and the FDA's adverse event reports.
Read article on Sepp Hasslberger's Health Supreme website
Showing posts with label Strattera. Show all posts
Showing posts with label Strattera. Show all posts
Monday, 27 October 2008
Strattera adverse effects: UK Medicines Agency refuses to act
Labels:
ADHD,
adverse side-effects,
Eli Lilly,
FDA,
Janne Larsson,
MHRA,
Strattera,
suicide
Thursday, 29 May 2008
Strattera Adverse Events: Deaths Mount - Will EU Health Authorities Intervene?
Will European Health Authorities act on reports of serious side-effects and deaths connected with the ADHD drug Strattera? Are 95 deaths, 965 reports of suicidal behaviour and some 60,000 reported adverse events enough to take action, asks Swedish researcher Janne Larsson in a letter to the UK's Medicines Agency.
Read article on Sepp Hasslberger's Health Supreme website
Read article on Sepp Hasslberger's Health Supreme website
Subscribe to:
Posts (Atom)